XML 36 R24.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2019
Accounting Policies [Abstract]  
Schedule of Basic Earnings Per Common Share

The following table shows the computation of basic net income (loss) per share of common stock for the three March 31, 2019 and 2018:

 

    For the     For the  
    Three Months Ended     Three Months Ended  
    March 31, 2019     March 31, 2018  
             
Numerator – net income (loss) attributable to Harrow Health, Inc.   $ 11,358     $ (3,513 )
Denominator – weighted average number of shares outstanding, basic     24,841,386       20,949,199  
Net income (loss) per share, basic   $ 0.46     $ (0.17 )
Schedule of Diluted Common Equivalent Shares

For three months ended March 31, 2019, the Company had net income. As a result, the Company computed diluted net income per share using the weighted-average number of common shares and dilutive common equivalent shares outstanding during those periods. Diluted common equivalent shares for the three months ended March 31, 2019, consisted of the following:

 

    March 31, 2019  
Diluted shares related to:        
Warrants     1,067,808  
Stock options     680,501  
Dilutive common equivalent shares     1,748,309  
Schedule of Diluted Earnings Per Common Share

The following table shows the computation of diluted net income (loss) per share of common stock for the three months ended March 31, 2019 and 2018:

 

    For the     For the  
    Three Months Ended     Three Months Ended  
    March 31, 2019     March 31, 2018  
             
Numerator – net income (loss) attributable to Harrow Health. Inc.   $ 11,358     $ (3,513 )
Denominator – weighted average number of shares outstanding, basic     24,841,386       20,949,199  
Dilutive common equivalent shares     1,748,309       -  
Number of shares used for diluted earnings per share computation     26,589,695       20,949,199  
Net income (loss) per share, diluted   $ 0.43     $ (0.17 )